Mixed Dyslipidemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-12-02
Clinical Trial Update: Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects [Phase 3]
Pfizer has withdrawn the Phase 3 trial evaluating bococizumab for lipid lowering in Asian subjects with primary hyperlipidemia or mixed dysl…